Leo Wealth LLC Acquires Shares of 2,317 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Leo Wealth LLC acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 2,317 shares of the exchange traded fund’s stock, valued at approximately $207,000.

Several other institutional investors and hedge funds also recently made changes to their positions in XBI. Avoro Capital Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $396,844,000. Healthcare of Ontario Pension Plan Trust Fund raised its stake in shares of SPDR S&P Biotech ETF by 103.3% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,771,000 shares of the exchange traded fund’s stock worth $129,318,000 after purchasing an additional 900,000 shares during the period. Employees Retirement System of Texas purchased a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter worth about $27,456,000. Blackstone Inc. grew its position in SPDR S&P Biotech ETF by 674.8% during the fourth quarter. Blackstone Inc. now owns 337,030 shares of the exchange traded fund’s stock valued at $30,093,000 after buying an additional 293,530 shares during the period. Finally, MBB Public Markets I LLC raised its position in SPDR S&P Biotech ETF by 67.0% in the third quarter. MBB Public Markets I LLC now owns 514,411 shares of the exchange traded fund’s stock worth $37,562,000 after acquiring an additional 206,337 shares during the period.

SPDR S&P Biotech ETF Stock Down 1.3 %

SPDR S&P Biotech ETF stock opened at $90.59 on Tuesday. The company has a market capitalization of $6.90 billion, a P/E ratio of 11.47 and a beta of 1.11. The firm has a 50 day moving average price of $89.10 and a 200-day moving average price of $89.98. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.